• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Purpose A systematic review of the literature was carried out to determine the role of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC) . ...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Zykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

TABRECTA (capmatinib) is an oral prescription medication from Novartis Pharmaceuticals Corporation, approved to treat adults with metastatic non-small cell lung cancer (NSCLC) that has a specific...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Pemetrexed is a prescription chemotherapy drug used to treat certain cancers, like non-small cell lung cancer and malignant pleural mesothelioma. It works by blocking folate metabolism in cancer...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Healthy individuals have few goblet cells in their airways, but in patients with hypersecretory diseases goblet-cell upregulation results in mucus hypersecretion, airway plugging, and death....

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Phosphoinositide 3-kinases (PI-3Ks) are enzymes that generate lipid second messenger molecules, resulting in the activation of multiple intracellular signalling cascades. These events regulate a...

• html